维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="Milowsky MI"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma显示文摘	NANUS DM GARINO A MILOWSKY MI	2004	Cancer2004，101，7：	1
2	Low incidence of periop-erative chemotherapy for stage Ⅲ bladder cancer 1998 to 2003:a report fromthe National Cancer Data Base显示文摘	David KA Milowsky MI Ritchey J	2007	J Urol2007，178，2：	1
3	Phase Ⅱ study of everolimus in metastatic urothelial cancer 显示文摘	Milowsky MI Lyer G Regazzi AM	2013	BJU Int2013，112，4：	1
4	Clinical use of monoclonal antibody huJ591 therapy: targeting prostate specific membrane antigen 显示文摘	Nanus DM Milowsky MI Kostakoglu L	2003	J Urology2003，170，6：	1
5	Advanced bladder ca-ncer:status of first-line chemotherapy and the search for active agents in the second-line setting显示文摘	Gallagher DJ Milowsky MI Bajorin DF	2008	Cancer2008，113，6：	1
6	Phase Ⅱ study of sunitinib in patients with metastatic urothelial cancer 显示文摘	Gallagher DJ Milowsky MI Gerst SR	2010	J Clin Oncol2010，28，8：	1
7	Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen显示文摘	Nanus DM Milowsky MI Kostakoglu L	2003	J Urol2003，170，62：	1
8	Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting 显示文摘	Gallagher DJ Milowsky MI Bajorin DF	2008	Cancer2008，113，6：	1
9	Neoadjuvant paradigm for accelerated drug development: an ideal model in bladder cancer 显示文摘	Chism DD Woods ME Milowsky MI	2013	Oncologist2013，18，8：	1
10	Clinical use of monoclonal antibody HuJ591 therapy: targeting prostate specific membrane antigen显示文摘	Nanus DM Milowsky MI Kostakoglu L	2003	Urology2003，170，62：	1
11	Survillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000 显示文摘	David KA Mallin K Milowsky MI	2009	Cancer2009，115，7：	1
12	Fibroblast growth factor receptor-3 in urothelial tumorigenesis 显示文摘	Iyer G Milowsky MI	2013	Urol Oncol2013，31，3：	1
13	Detection of circulating tumor cells in patients with urothelial cancer显示文摘	Gallagher D J Milowsky MI Ishill N	2009	Ann Oncol2009，20，2：	1
14	Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy显示文摘	Batar A Bajorin DF Milowsky MI	2011	Ther Adv Urol2011，3，：	1
15	Neoadjuvant Therapy in Muscle - Invasive Bladder Cancer:A Model for Rational Accelerated Drug Develop- ment显示文摘	Balar AV Milowsky MI	2015	Urol Clin North Am2015，42，2：	1
16	Bladder cancer 显示文摘	Gallagher DJ Milowsky MI	2009	Curr Treat Options Oncol2009，10，34：	1
17	Phase II study of everolimus in metastatic urothelial cancer显示文摘	MILOWSKY MI IYER G REGAZZI AM	2013	BJU Int2013，112，：	1
18	Genome sequencing identifies a basis for everolimus sensitivity显示文摘	IYER G HANRAHAN AJ MILOWSKY MI	2012	Sci- ence2012，，：	1
19	Phase II studyof sunitinib in patients with metastatic urothelial cancer显示文摘	Gallagher DJ Milowsky MI Gerst SR	2010	J Clin Oncol2010，28，：	1
20	Detection of circulating tumor cells inpatients with urothelial cancer 显示文摘	Gallagher DJ Milowsky MI Ishill N	2009	Ann Oncol2009，20，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示